Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Other Non-Current Liabilities: 2022-2024

Historic Other Non-Current Liabilities for P3 Health Partners (PIII) over the last 3 years, with FY2024 value amounting to $10.3 million.

  • P3 Health Partners' Other Non-Current Liabilities fell 6182.17% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 6182.17%. This contributed to the annual value of $10.3 million for FY2024, which is 11014.88% up from last year.
  • As of FY2024, P3 Health Partners' Other Non-Current Liabilities stood at $10.3 million, which was up 11014.88% from $4.9 million recorded in FY2023.
  • Over the past 5 years, P3 Health Partners' Other Non-Current Liabilities peaked at $10.3 million during FY2024, and registered a low of $4.8 million during FY2022.
  • In the last 3 years, P3 Health Partners' Other Non-Current Liabilities had a median value of $4.9 million in 2023 and averaged $6.7 million.
  • In the last 5 years, P3 Health Partners' Other Non-Current Liabilities soared by 235.71% in 2023 and then soared by 11014.88% in 2024.
  • Annual analysis of 3 years shows P3 Health Partners' Other Non-Current Liabilities stood at $4.8 million in 2022, then increased by 2.36% to $4.9 million in 2023, then skyrocketed by 110.15% to $10.3 million in 2024.
  • Its Other Non-Current Liabilities stands at $10.3 million for FY2024, versus $4.9 million for FY2023 and $4.8 million for FY2022.